The European Investment Bank has granted a 20 million Euro loan to Israeli biotech BiondVax to fund the Phase III trials of its Universal Flu Vaccine.
http://www.globes.co.il/en/article-20m-eu-loan-to-fund-biondvax-phase-iii-trial-1001193180
EU loan for flu vaccine trial
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.